Stroke for the Future. The vision for comprehensive stroke care pathways in Ireland conference
iPASTAR (Improving pathways for acute stroke and rehabilitation) research team
Event Date | 6 Nov 2024 |
The conference title is ‘Stoke for the Future. The vision for comprehensive stroke care pathways in Ireland’. It will be led by the iPASTAR (Improving pathways for acute stroke and rehabilitation) research team and include keynote speeches from leaders in the stroke community, including Prof. Michael Hill, University of Calgary, Canada. Prof. Bo Norrving, Lund University, Sweden. Prof. Peter Langhorne, Emeritus Professor, University of Glasgow. Prof. Peter Kelly (President of the European Stroke Organization). Prof. Peter McMeekin, North Cumbria University, and Prof. James Faulkner, University of Winchester.
iPASTAR (Improving pathways for acute stroke and rehabilitation) is a collaborative doctoral training award funded by the Health Research Board of Ireland, Collaborative Doctoral Awards Programme 2019, and hosted by RCSI and UCD. It is led by Prof. David Williams (RCSI) and Prof. Frances Horgan (RCSI).
The iPASTAR PhD research scholars will present an update on their projects, which are focusing on the delivery of stroke care for patients, from the hospital to rehabilitation in the community, and living well after stroke. The symposium participants will hear from our PPI partners and hear perspectives from stroke survivors on their experience of life after stroke and being involved in iPASTAR.
Full programme details will be available shortly, but until then, please save the date in your diaries and feel free to invite colleagues and contacts who may be interested in attending. We look forward to welcoming you on November 6th, 2024.
If you have any queries, please get in touch.
Anne Moore
iPASTAR CDA Programme Manager
CLASP- Programme Manager
iPASTAR, School of Population Health
Beaux Lane House D2 M: +353 874144982
E: [email protected] W: www.rcsi.com
Adverts for third party services, courses, vacancies or products do not constitute or imply endorsement, recommendation or validation by AOTI.